Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Anavex Life Sciences
(NASDAQ:AVXL)
Intraday
$3.80
-0.27
[-6.63%]
After-Hours
$3.80
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$3.80
-0.27
[-6.63%]
At close: Apr 18
$3.80
0
[0.00%]
After Hours: 7:39PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Anavex Life Sciences Stock (NASDAQ:AVXL)
Anavex Life Sciences Stock (NASDAQ: AVXL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 18, 2024
Anavex Life Sciences Announced That The First Patient In Its Phase 2 Study Of ANAVEX3-71 For Schizophrenia Has Been Screened Ahead Of Schedule
Benzinga Newsdesk
-
Mar 18, 2024, 7:35AM
Wednesday, February 07, 2024
Anavex Life Sciences Q1 EPS $(0.11) Beats $(0.14) Estimate; Cash And Cash Equivalents Of $143.8M
Benzinga Newsdesk
-
Feb 7, 2024, 7:32AM
Earnings Scheduled For February 7, 2024
Benzinga Insights
-
Feb 7, 2024, 5:13AM
Tuesday, February 06, 2024
Anavex Life Sciences Earnings Preview
Benzinga Insights
-
Feb 6, 2024, 2:01PM
Wednesday, January 24, 2024
Peering Into Anavex Life Sciences's Recent Short Interest
Benzinga Insights
-
Jan 24, 2024, 1:45PM
Anavex Life Sciences Announced A Peer-reviewed Publication In Clinical Pharmacology In Drug Development, Findings From The ANAVEX 3-71 First-in-human Study Which Achieved Its Safety Objectives
Benzinga Newsdesk
-
Jan 24, 2024, 7:35AM
Tuesday, January 23, 2024
Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years
Benzinga Insights
-
Jan 23, 2024, 9:31AM
Thursday, January 18, 2024
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,400 Today
Benzinga Insights
-
Jan 18, 2024, 10:00AM
Tuesday, January 16, 2024
Anavex Life Sciences Has Initiated FDA-Cleared Placebo-controlled Phase 2 Trial Of ANAVEX3-71 For The Treatment Of Schizophrenia, Which Is Expected To Begin In Q2 2024
Benzinga Newsdesk
-
Jan 16, 2024, 7:32AM
Monday, January 08, 2024
Anavex Life Sciences Reports Grant Of US Patent Covering Blarcamesine (ANAVEX2-73) For Treatment Of Neurodevelopmental Disorders
Benzinga Newsdesk
-
Jan 8, 2024, 7:51AM
Wednesday, January 03, 2024
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 3, 2024, 12:58PM
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Jan 3, 2024, 10:24AM
HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Lowers Price Target to $40
Benzinga Newsdesk
-
Jan 3, 2024, 8:33AM
Tuesday, January 02, 2024
Crude Oil Down 2%; Tesla Deliveries Top Estimates
Avi Kapoor
-
Jan 2, 2024, 2:17PM
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 2, 2024, 1:35PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 2, 2024, 12:31PM
Dow Turns Higher; Anavex Life Sciences Shares Plunge
Avi Kapoor
-
Jan 2, 2024, 12:15PM
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
Avi Kapoor
-
Jan 2, 2024, 11:47AM
"A Single Drug And Multiple Study Failures Leave Anavex With Nothing But Cash" - StatNews
Benzinga Newsdesk
-
Jan 2, 2024, 11:39AM
Dow Down 100 Points; US Manufacturing PMI Falls In December
Avi Kapoor
-
Jan 2, 2024, 9:53AM
Why Clinical Stage Biopharmaceutical Company Anavex Shares Are Tanking Today
Nabaparna Bhattacharya
-
Jan 2, 2024, 9:23AM
Anavex Life Sciences shares are trading lower after the company announced the Clinical Global Impression – Improvement scale co-primary endpoint of its Phase 2/3 EXCELLENCE clinical trial was not met.
Benzinga Newsdesk
-
Jan 2, 2024, 8:57AM
Anavex Life Sciences Unveils Encouraging Phase 2/3 Trial Results for Rett Syndrome Treatment; Co-Primary Endpoint, The Clinical Global Impression, Was Not Met.
Benzinga Newsdesk
-
Jan 2, 2024, 8:04AM
Wednesday, December 20, 2023
Anavex Life Sciences Reveals First Entire Clinical Gene Pathway Data of ANAVEX 2-73 From AVATAR Study In Patients With Rett Syndrome
Benzinga Newsdesk
-
Dec 20, 2023, 7:34AM
Tuesday, December 19, 2023
Anavex Life Sciences shares are trading higher after the company announced it received agreement from the CHMP for the submission of a Marketing Authorisation application of oral blarcamesine for Alzheimer's disease.
Benzinga Newsdesk
-
Dec 19, 2023, 12:39PM
Anavex Received Agreement From CHMP) For The Submission Of A Marketing Authorization Application Of Oral Blarcamesine For Alzheimer's Disease
Charles Gross
-
Dec 19, 2023, 7:36AM
Tuesday, November 28, 2023
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $54 Price Target
Benzinga Newsdesk
-
Nov 28, 2023, 7:02AM
Monday, November 27, 2023
Crude Oil Falls; RedHill Biopharma Shares Spike Higher
Lisa Levin
-
Nov 27, 2023, 2:30PM
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Nov 27, 2023, 1:41PM
Nasdaq Moves Higher; US New Home Sales Fall In October
Lisa Levin
-
Nov 27, 2023, 12:21PM
Anavex Life Sciences shares are trading lower after the company reported Q4 financial results.
Benzinga Newsdesk
-
Nov 27, 2023, 9:56AM
Recap: Anavex Life Sciences Q4 Earnings
Benzinga Insights
-
Nov 27, 2023, 8:25AM
Anavex Life Sciences Q4 EPS $(0.12) Beats $(0.15) Estimate
Benzinga Newsdesk
-
Nov 27, 2023, 8:06AM
Wednesday, November 22, 2023
Anavex Life Sciences Announces Grant Of U.S. Patent Covering Blarcamesine For Treatment Of Insomnia Or Anxiety
Benzinga Newsdesk
-
Nov 22, 2023, 8:01AM
Monday, November 20, 2023
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Nov 20, 2023, 2:35PM
Anavex Stock Is Moving Higher Monday: What's Going On?
Adam Eckert
-
Nov 20, 2023, 9:08AM
Anavex Initiates Regulatory Submission Of Oral Blarcamesine For Alzheimer's Disease To European Medicines Agency
Benzinga Newsdesk
-
Nov 20, 2023, 8:04AM
Wednesday, October 25, 2023
General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
Oct 25, 2023, 11:29AM
Anavex Life Sciences Reports New Publication In Scientific Journal Demonstrating The Potential Of ANAVEX 3-71 To Prevent Cognitive Decline In Alzheimer's Disease
Benzinga Newsdesk
-
Oct 25, 2023, 8:06AM
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 10, 2023, 1:09PM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 2, 2023, 1:00PM
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 28, 2023, 2:32PM
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 26, 2023, 12:04PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Thursday, September 14, 2023
Anavex Life Sciences Announced That A Follow-on Analysis Of The Landmark Phase 2B/3 Study Of Blarcamesine (ANAVEX2-73) Demonstrated A Statistically Significant Slowing In Cognitive Decline Associated With Alzheimer's Disease
Benzinga Newsdesk
-
Sep 14, 2023, 7:32AM
Wednesday, August 09, 2023
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Lisa Levin
-
Aug 9, 2023, 3:17PM
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
Aug 9, 2023, 2:03PM
Tuesday, August 08, 2023
Anavex Life Sciences Q3 EPS $(0.14) Beats $(0.17) Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 7:33AM
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $54 Price Target
Benzinga Newsdesk
-
Aug 8, 2023, 6:19AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch